Dr. Reddy's Laboratories

We recently signed an MoU with the Government of Telangana for strategic partnerships for the Young India Skill University (YISU). The Memoranda of Understanding (MoUs) were signed in the presence of Telangana Chief Minister, Revanth Reddy. Through this partnership, we aim to bridge the gap between skilled talent and private sector job opportunities. YISU is an initiative designed to offer practical, industry-relevant training to prepare youth for the demands of today’s competitive job market. The primary objective of these MoUs is to create a seamless pipeline between academic training and job placements. By aligning training programs with industry needs, YISU ensures that graduates possess the skills employers seek. In November, we launched our first batch of the Pharma Manufacturing Associate Programme in collaboration with YISU. The first batch is specifically designed for young women with B.Sc degrees, providing them with comprehensive training over a period of six months to equip them with the skills needed to operate machinery in formulation operations. Upon successful completion and certification, they will be offered opportunities within our manufacturing sites. This program reaffirms our commitment to skilling young talent and building a strong technical cadre. #YoungIndiaSkillUniversity #BridgingGaps #WeAreDrReddys #GoodHealthCantWait

📜 𝗥𝗲𝗮𝗱 𝗮𝗯𝗼𝘂𝘁 𝘁𝗵𝗲 𝗹𝗮𝘁𝗲𝘀𝘁 𝗮𝗱𝘃𝗮𝗻𝗰𝗲𝗺𝗲𝗻𝘁𝘀 𝗶𝗻 𝗶𝗺𝗺𝘂𝗻𝗼-𝗼𝗻𝗰𝗼𝗹𝗼𝗴𝘆 𝗶𝗻 𝗼𝘂𝗿 𝘄𝗵𝗶𝘁𝗲𝗽𝗮𝗽𝗲𝗿 At Aurigene, we are driving forward in the groundbreaking field of immuno-oncology 🚀, where we’re committed to discovering 🔬 transformative treatments and pioneering innovative therapeutic approaches to combat cancer.    𝗪𝗵𝗮𝘁 𝗶𝘀 𝗜𝗺𝗺𝘂𝗻𝗼-𝗢𝗻𝗰𝗼𝗹𝗼𝗴𝘆 (𝗜𝗢)?  Immuno-oncology is redefining the landscape of 🎗️ cancer treatment by mobilizing the body’s immune system to recognize and eliminate cancer cells 🦠. This approach is paving the way for new, targeted therapies, bringing fresh hope to patients and families worldwide 🌏.    🚀 𝗥𝗲𝗮𝗱𝘆 𝘁𝗼 𝗟𝗲𝗮𝗿𝗻 𝗠𝗼𝗿𝗲?  Download our latest whitepaper to explore these cutting-edge breakthroughs and gain insight into the future of cancer therapy 🧬.  👉 Access here: https://lnkd.in/gwvHsR4e 🔗 Visit us: www.aurigeneservices.com  📧 For inquiries, reach out: [email protected]   #CancerCare #ImmunoOncology #Aurigene #InnovativeTherapies #FutureofHealthcare #CancerResearch

Pleased to share that we have been recognised by TIME Magazine and Statista in their global list of top performing companies faring well financially while also doing right by the environment. In other words, companies around the world doing well across parameters in revenue growth, financial stability and environmental stewardship. The rigorous methodology scrutinised data between 2021-2023 from thousands of companies on revenue growth (relative growth and within the industry), financial stability (Piotroski F-Score, Altman Z-Score, and profit), and environmental impact (greenhouse gas emissions, waste, water use, green energy use). As the article notes, “It may be the most important question facing businesses in the fraught age of climate crisis and stakeholder capitalism: can a company do well while doing right by the environment?” As a company known for its strong balance sheet, financial health and discipline on the one hand, and leadership in sustainability and ESG on the other, our endeavour is to contribute to the well-being of patients, people, planet, and deliver value to stakeholders. To read more, click here: https://lnkd.in/esms_43j #SustainableGrowth #DrReddysXSustainability #ESG #Sustainability #GoodHealthCantWait #WeAreDrReddys

We are pleased to welcome Chiranjoy Chowdhuri into the Dr. Reddy's family as Head of Data and Artificial Intelligence CoE in the Digital and Process Excellence (DPEx) team in Hyderabad. In his role, Chiranjoy will lead the design and build of our capabilities in this area, and identify opportunities to drive impact. Chiranjoy is a Data and AI leader with more than a decade and a half of experience with leading global companies in and beyond pharma. He has successfully led data science and analytics teams and programmes with significant business impact. In 2022, Chiranjoy was recognized as one of the 100 Most Influential AI Leaders in India by Analytics India Magazine. He is also an adjunct faculty member for data science and analytics at various academic institutions. With AI emerging as an important capability in driving growth and productivity, we look forward to Chiranjoy's leadership in steering our data and AI journey with meaningful business impact. #GoodHealthCantWait #WeAreDrReddys

CEO of our Branded Markets business (India & Emerging Markets), M.V. Ramana, reiterates our growth strategy in India – growing our base business and big brands coupled with our innovation agenda pillars of novel molecules, digital therapeutics and consumer health. In recent months, our launch of the drug-free migraine management device Nerivio followed by the app Daily Bloom for IBS have marked our foray into digital therapeutics, while our consumer health journey in India saw the formation of a unique joint venture in the form of the Dr. Reddy's and Nestlé Health Science Limited. Under our novel molecules pillar, we recently announced the introduction of the New Biological Entity, Toripalimab, in India under the brand name Zytorvi® for recurrent or metastatic nasopharyngeal carcinoma – making India only the 3rd country in the world to receive access to this first and only immuno-oncology drug to be approved for RM-NPC. We look forward to extending this launch to several other Emerging Markets in the near future. #GoodHealthCantWait #WeAreDrReddys

Pleased to share that we were named winner in the AI Pioneer category among organisations with 10,000+ employees at the LinkedIn Talent Awards! This award is testament to our commitment to advancing AI skills through dedicated training and development programs. Benchmarked against leading industry firms, this achievement underscores our commitment to the pursuit of excellence and innovation. As we celebrate this milestone, we continue to invest in AI training and development to ensure continuous improvement and excellence. #LinkedInTalentAwards #AIPioneer #WeAreDrReddys #GoodHealthCantWait

We look forward to attending the #ASHP2024! Our Specialty Rx and Biologics teams will be at Booth #633. Talk to our Specialty Rx team about our latest products and meet our North America Biologics team. #ASHP2024 #GoodHealthCantWait #WeAreDrReddys

We continue our conversations on inclusivity on International Day of Persons with Disability. Our Diversity, Equity and Inclusion (DEI) journey is young, and we have a long way to go. With each step, we try to learn and improve our effort to fairly represent the society we live in. Through the GROW PwD programme, we have supported 4,629 aspirants. GROW PwD (Persons with Disabilities) is our multi-partner community initiative in collaboration with Dr. Reddy’s Foundation to bring more persons with disabilities (between ages 18-35) into the workforce through a two-month core employability skills training programme on communication, aptitude, computer operation, sector readiness, interview skills and more. The programme works to advance inclusive employment opportunities for youth from low-income households. The skill development centres, equipped with accessible infrastructure and trained professionals such as sign-language interpreters and special educators empower aspiring individuals to pursue jobs aligned with their competencies and market demands. The programme serves 13 different types of disabilities including physical, speech, hearing disabilities, vision impairment and intellectual disability. A tailored curriculum is administered to cater to their diverse learning needs. We are grateful and proud of the work done by Dr. Reddy's Foundation, and of the trust our aspirants place in us. In 2022, our GROW PwD initiative was recognised by the President of India with a National Award for the Empowerment of Persons with Disabilities. We continue our effort to educate ourselves and empower the differently-abled amongst us by holding sensitisation sessions on hiring, inclusive language, personal space, infrastructure, and empowering differently-abled colleagues to speak up about their needs, requirements and experiences. #HumansOfDrReddys #DrReddysXSustainability #GoodHealthCantWait #WeAreDrReddys #IDPD #ESG #Sustainability #40YearsOfDrReddys #SDG10 (reduced inequalities) #InternationalDayOfPersonsWithDisabilities

#ICYMI (in case you missed it) - here is a recap of our launch of Toripalimab (Zytorvi®️) in India, the significance of being only the 3rd country in the world with access to the drug and same-year launch as the U.S.! (3/3) #FirstInClassDrug #NasopharyngealCarcinoma #SDG3(good health and well-being) #GoodHealthCantWait #WeAreDrReddys

Time for the #GoodHealthCantWait quiz! Let's see if you have read our latest announcement.